AbbVie On A STEAP Learning Curve In ADCs

 
• By Andrew McConaghie
AbbVie building
AbbVie continues to manage Humira erosion despite rising biosimilar market share • Source: Alamy

More from Clinical Trials

More from Therapy Areas